Novo A/S Acquires Xellia Pharmaceuticals for US$ 700 million
Tuesday, May 21, 2013
With this acquisition Novo expands its long-term investment portfolio with a further major life-science company in Denmark.

ABPI to Take Lead Role in Representing Vaccine Industry
Tuesday, May 21, 2013
The ABPI announced that it will now represent the vaccine industry to Government and healthcare stakeholders.

Novozymes Biopharma Helps Innovative Dry Eye Therapy Move into Clinical Trials
Monday, May 20, 2013
A novel ophthalmic solution has recently obtained FDA approval to undergo Phase I/II clinical trials in the United States.

TherapeuticsMD Elects Jules A. Musing to Board of Directors
Friday, May 17, 2013
TherapeuticsMD, Inc. announced the election of Jules A. Musing, a former senior executive at Johnson & Johnson, to its Board of Directors, effective immediately.

ImmunoCellular Therapeutics Announces Issuance of Key Patent for Cancer Vaccine Target
Friday, May 17, 2013
The US Patent and Trademark Office (USPTO) has issued a patent covering methods of use of interleukin 13-receptor alpha 2 protein (IL-13Ra2) in cancer immunotherapy.

Results of the ROTAVAC Rotavirus Vaccine Study in India
Thursday, May 16, 2013
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.

Halo Pharma Announces Investment and Formal Collaboration with Altus
Thursday, May 16, 2013
Halo Pharma has taken a minority ownership position in, and established a formal collaboration with, Altus Formulation Inc.

Navidea Biopharmaceuticals Signs Agreement with Nordion
Thursday, May 16, 2013
Nordion to produce and distribute supplies of 123I-labeled drug product NAV5001 for late-phase clinical trials.

Bend Research Expands Analytical Sciences Capabilities
Wednesday, May 15, 2013
Bend Research Inc. announced that it has expanded its Good Manufacturing Practice (GMP) analytical capabilities and capacity for pharmaceutical development.

<<	1 2 3 4 5 6 7	>>
Showing Results 1 - 10 of 704